🏆 Deal of the Week · CW 13/2025
AMBOSS raised EUR 240 million in a venture financing round, with the valuation remaining undisclosed. The round was backed by KIRKBI, Lightrock, and M&G Investments. This transaction was recognised as Deal of the Week for KW 13/2025 on Venionaire DealMatrix.
AMBOSS — key deal facts
| Company | AMBOSS |
| Founded | 2012 |
| Headquarters | Berlin, Germany |
| Amount raised | EUR 240m |
| Valuation | Valuation Remains Undisclosed |
| Round | Venture – Series Unknown |
| Investors | KIRKBI, Lightrock, M&G Investments |
| Sectors | Health Cares |
Who invested in AMBOSS?
The round was co-funded by KIRKBI, the private investment arm of the Kirk Kristiansen family and owner of the LEGO brand, alongside impact-focused growth investor Lightrock and global asset manager M&G Investments. The investor mix is notable for combining a family-office-backed strategic vehicle, an impact-growth platform, and a large institutional asset manager — a coalition that signals conviction in AMBOSS's long-term commercial and social relevance. No single lead investor has been publicly designated.
What does AMBOSS do?
AMBOSS is a Berlin-based medical education and clinical decision-support company founded in 2012 by physicians, including co-founder and co-CEO Benedikt Hochkirchen. Its platform serves more than one million healthcare professionals across more than 180 countries, offering an interactive medical library, a high-yield question bank for licensing and board examinations, and evidence-based clinical decision tools. The company maintains offices in New York, Cologne, and Cagliari in addition to its Berlin headquarters.
AMBOSS valuation & multiples
No verified revenue or EBITDA figures are publicly available for AMBOSS, so EV/Sales and EV/EBITDA multiples cannot be calculated at this time. As comparable benchmarks become available, deal-level valuation analysis will be updated accordingly. For current sector-level transaction multiples in health-care technology and medical education, refer to the Venionaire DealMatrix Health Care sector multiples pages.
Frequently asked questions
How much did AMBOSS raise in its Venture – Series Unknown?
AMBOSS raised EUR 240 million in a venture financing round, announced in KW 13/2025.
What is AMBOSS's valuation?
AMBOSS's valuation was not disclosed in connection with this financing round.
Who invested in AMBOSS?
The round was funded by KIRKBI, Lightrock, and M&G Investments.
When was AMBOSS founded and where is it based?
AMBOSS was founded in 2012 and is headquartered in Berlin, Germany.
Source: original announcement — read the full report.